In practice, EGFR-targeted fluorescence imaging achieves modest optical tumor-to-normal ratios (16), which are not always representative of actual differences in cellular expression of EGFR among tumor and normal tissues (14, 17–19) due to confounding effects involved in the entire fluorescence process from illumination to detection. This evidence concerns the gene EGFR and neoplasm.